Kirit Singh, MBBS (he/him/his)

PhD. Candidate
Duke University
Durham, NC, US

Dr Kirit Singh MBBS, MSc. PhD candidate in the Department of Neurosurgery & Brain Tumor Immunotherapy Program, Duke University. Dr Singh's research focused on studying novel methods for enriching tumors with lymphocytes and enhancing T cell dependent immunotherapies. He also has designed and is involved in multiple surgical window of opportunity trials that seek to understand whether drugs reach intracranial tumors and exert a biological effect (PESKe: NCT04937413, FLIrT: NCT05634707). Previously he worked in the National Health Service as a junior neurosurgical resident, after completion of his medical training at Barts and the London, UK.

Disclosure(s): No financial relationships to disclose

Presentation(s):

• Adoptive lymphocyte transfer increases intra-tumoral T cell counts during lymphocytic sequestration and augments immunostimulatory therapy in the CNS of mice with established glioma

  Friday, May 3, 2024
  1:25 PM – 1:29 PM CT

• Journal of Neuro-Oncology Award: Summary findings of a surgical window-of-opportunity clinical trial evaluating the PCSK9 inhibitor Evolocumab in patients with glioma

  Saturday, May 4, 2024
  2:24 PM – 2:28 PM CT